nodes	percent_of_prediction	percent_of_DWPC	metapath
Methsuximide—Primidone—epilepsy syndrome	0.0762	0.335	CrCtD
Methsuximide—CACNA1G—epilepsy syndrome	0.0595	0.47	CbGaD
Methsuximide—Phenobarbital—epilepsy syndrome	0.0562	0.247	CrCtD
Methsuximide—CACNA1H—epilepsy syndrome	0.0536	0.424	CbGaD
Methsuximide—Phenytoin—epilepsy syndrome	0.0522	0.23	CrCtD
Methsuximide—Clobazam—epilepsy syndrome	0.0426	0.187	CrCtD
Methsuximide—CACNA1G—Trimethadione—epilepsy syndrome	0.0366	0.292	CbGbCtD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Lacosamide—epilepsy syndrome	0.0283	0.0875	CiPCiCtD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Levetiracetam—epilepsy syndrome	0.0283	0.0875	CiPCiCtD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Lamotrigine—epilepsy syndrome	0.0283	0.0875	CiPCiCtD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Trimethadione—epilepsy syndrome	0.0283	0.0875	CiPCiCtD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Fosphenytoin—epilepsy syndrome	0.0283	0.0875	CiPCiCtD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Primidone—epilepsy syndrome	0.0283	0.0875	CiPCiCtD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Felbamate—epilepsy syndrome	0.0283	0.0875	CiPCiCtD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Oxcarbazepine—epilepsy syndrome	0.0283	0.0875	CiPCiCtD
Methsuximide—CACNA1I—Zonisamide—epilepsy syndrome	0.0243	0.194	CbGbCtD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Valproic Acid—epilepsy syndrome	0.0215	0.0663	CiPCiCtD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Gabapentin—epilepsy syndrome	0.0215	0.0663	CiPCiCtD
Methsuximide—CACNA1G—Zonisamide—epilepsy syndrome	0.0183	0.146	CbGbCtD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Zonisamide—epilepsy syndrome	0.0163	0.0503	CiPCiCtD
Methsuximide—CACNA1H—Zonisamide—epilepsy syndrome	0.0148	0.118	CbGbCtD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Carbamazepine—epilepsy syndrome	0.0138	0.0427	CiPCiCtD
Methsuximide—CYP2C19—epilepsy syndrome	0.0134	0.106	CbGaD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Phenytoin—epilepsy syndrome	0.0123	0.0381	CiPCiCtD
Methsuximide—Decreased Central Nervous System Disorganized Electrical Activity—Topiramate—epilepsy syndrome	0.0118	0.0363	CiPCiCtD
Methsuximide—Glutethimide—Primidone—epilepsy syndrome	0.00888	0.0612	CrCrCtD
Methsuximide—Ethotoin—Primidone—epilepsy syndrome	0.00816	0.0563	CrCrCtD
Methsuximide—Primidone—Phenobarbital—epilepsy syndrome	0.008	0.0552	CrCrCtD
Methsuximide—Antipyrine—Clobazam—epilepsy syndrome	0.00794	0.0547	CrCrCtD
Methsuximide—Primidone—Phenytoin—epilepsy syndrome	0.00744	0.0513	CrCrCtD
Methsuximide—Methylphenobarbital—Primidone—epilepsy syndrome	0.00705	0.0486	CrCrCtD
Methsuximide—Methylphenobarbital—Fosphenytoin—epilepsy syndrome	0.00705	0.0486	CrCrCtD
Methsuximide—Phensuximide—Primidone—epilepsy syndrome	0.00661	0.0456	CrCrCtD
Methsuximide—Glutethimide—Phenobarbital—epilepsy syndrome	0.00654	0.0451	CrCrCtD
Methsuximide—Glutethimide—Phenytoin—epilepsy syndrome	0.00608	0.042	CrCrCtD
Methsuximide—Ethotoin—Phenobarbital—epilepsy syndrome	0.00602	0.0415	CrCrCtD
Methsuximide—Phenobarbital—Primidone—epilepsy syndrome	0.0059	0.0407	CrCrCtD
Methsuximide—Methylphenobarbital—Phenobarbital—epilepsy syndrome	0.0052	0.0358	CrCrCtD
Methsuximide—Phenytoin—Fosphenytoin—epilepsy syndrome	0.0051	0.0352	CrCrCtD
Methsuximide—Phenytoin—Primidone—epilepsy syndrome	0.0051	0.0352	CrCrCtD
Methsuximide—Phenobarbital—Amobarbital—epilepsy syndrome	0.00492	0.0339	CrCrCtD
Methsuximide—Methylphenobarbital—Phenytoin—epilepsy syndrome	0.00483	0.0333	CrCrCtD
Methsuximide—Phenobarbital—Phenytoin—epilepsy syndrome	0.00404	0.0279	CrCrCtD
Methsuximide—Phenytoin—Phenobarbital—epilepsy syndrome	0.00376	0.0259	CrCrCtD
Methsuximide—Phensuximide—Clobazam—epilepsy syndrome	0.0037	0.0255	CrCrCtD
Methsuximide—Ketazolam—Midazolam—epilepsy syndrome	0.00363	0.025	CrCrCtD
Methsuximide—Ketazolam—Clobazam—epilepsy syndrome	0.00348	0.024	CrCrCtD
Methsuximide—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00347	0.0278	CbGbCtD
Methsuximide—Phensuximide—Diazepam—epilepsy syndrome	0.00344	0.0237	CrCrCtD
Methsuximide—Ketazolam—Diazepam—epilepsy syndrome	0.00324	0.0223	CrCrCtD
Methsuximide—CYP2C19—Trimethadione—epilepsy syndrome	0.00323	0.0258	CbGbCtD
Methsuximide—CYP2C19—Felbamate—epilepsy syndrome	0.00323	0.0258	CbGbCtD
Methsuximide—Phenytoin—Carbamazepine—epilepsy syndrome	0.00322	0.0222	CrCrCtD
Methsuximide—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00303	0.0243	CbGbCtD
Methsuximide—CYP2C19—Clobazam—epilepsy syndrome	0.00263	0.021	CbGbCtD
Methsuximide—CYP2C19—Carbamazepine—epilepsy syndrome	0.00218	0.0174	CbGbCtD
Methsuximide—CYP2C19—Primidone—epilepsy syndrome	0.00204	0.0163	CbGbCtD
Methsuximide—Clobazam—Midazolam—epilepsy syndrome	0.00197	0.0136	CrCrCtD
Methsuximide—Clobazam—Oxcarbazepine—epilepsy syndrome	0.00197	0.0136	CrCrCtD
Methsuximide—CYP2C19—Phenytoin—epilepsy syndrome	0.00196	0.0156	CbGbCtD
Methsuximide—CYP2C19—Propofol—epilepsy syndrome	0.00182	0.0146	CbGbCtD
Methsuximide—Clobazam—Diazepam—epilepsy syndrome	0.00176	0.0121	CrCrCtD
Methsuximide—CYP2C19—Phenobarbital—epilepsy syndrome	0.00174	0.0139	CbGbCtD
Methsuximide—CYP2C19—Diazepam—epilepsy syndrome	0.00165	0.0132	CbGbCtD
Methsuximide—CYP2C19—Zonisamide—epilepsy syndrome	0.00161	0.0129	CbGbCtD
Methsuximide—CYP2C19—Valproic Acid—epilepsy syndrome	0.0013	0.0104	CbGbCtD
Methsuximide—CYP2C19—Topiramate—epilepsy syndrome	0.00118	0.00939	CbGbCtD
Methsuximide—CACNA1I—telencephalon—epilepsy syndrome	0.000332	0.188	CbGeAlD
Methsuximide—CACNA1G—telencephalon—epilepsy syndrome	0.000228	0.129	CbGeAlD
Methsuximide—CACNA1I—cerebellum—epilepsy syndrome	0.000184	0.104	CbGeAlD
Methsuximide—CACNA1I—brain—epilepsy syndrome	0.00015	0.0848	CbGeAlD
Methsuximide—CACNA1G—head—epilepsy syndrome	0.000142	0.0802	CbGeAlD
Methsuximide—CACNA1G—nervous system—epilepsy syndrome	0.000134	0.0761	CbGeAlD
Methsuximide—CACNA1G—central nervous system—epilepsy syndrome	0.000129	0.0732	CbGeAlD
Methsuximide—CACNA1G—cerebellum—epilepsy syndrome	0.000126	0.0716	CbGeAlD
Methsuximide—CACNA1G—brain—epilepsy syndrome	0.000103	0.0581	CbGeAlD
Methsuximide—CACNA1H—nervous system—epilepsy syndrome	8.79e-05	0.0498	CbGeAlD
Methsuximide—CACNA1H—cerebellum—epilepsy syndrome	8.27e-05	0.0468	CbGeAlD
Methsuximide—CACNA1H—brain—epilepsy syndrome	6.72e-05	0.038	CbGeAlD
Methsuximide—Phensuximide—CACNA1G—epilepsy syndrome	5.41e-05	0.0401	CrCbGaD
Methsuximide—Ethotoin—SCN8A—epilepsy syndrome	5.29e-05	0.0392	CrCbGaD
Methsuximide—Phensuximide—CACNA1H—epilepsy syndrome	4.87e-05	0.0361	CrCbGaD
Methsuximide—Ethotoin—SCN9A—epilepsy syndrome	4.28e-05	0.0317	CrCbGaD
Methsuximide—Ethotoin—SCN3A—epilepsy syndrome	4.09e-05	0.0304	CrCbGaD
Methsuximide—Glutethimide—GABRG2—epilepsy syndrome	3.97e-05	0.0295	CrCbGaD
Methsuximide—Ethotoin—SCN4A—epilepsy syndrome	3.93e-05	0.0292	CrCbGaD
Methsuximide—Clobazam—SLC6A1—epilepsy syndrome	3.87e-05	0.0287	CrCbGaD
Methsuximide—CACNA1G—Developmental Biology—SCN1A—epilepsy syndrome	3.78e-05	0.00218	CbGpPWpGaD
Methsuximide—CACNA1H—NCAM signaling for neurite out-growth—IL6ST—epilepsy syndrome	3.74e-05	0.00216	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—CNTN2—epilepsy syndrome	3.71e-05	0.00214	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—CNTN2—epilepsy syndrome	3.71e-05	0.00214	CbGpPWpGaD
Methsuximide—CYP2C19—Tamoxifen metabolism—CYP2D6—epilepsy syndrome	3.7e-05	0.00214	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—SLIT2—epilepsy syndrome	3.67e-05	0.00212	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—ANK3—epilepsy syndrome	3.67e-05	0.00212	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—CACNB4—epilepsy syndrome	3.66e-05	0.00212	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—SCN1A—epilepsy syndrome	3.66e-05	0.00212	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—SCN1B—epilepsy syndrome	3.66e-05	0.00212	CbGpPWpGaD
Methsuximide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	3.56e-05	0.00206	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—ANK3—epilepsy syndrome	3.55e-05	0.00205	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—SLIT2—epilepsy syndrome	3.55e-05	0.00205	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—ANK3—epilepsy syndrome	3.55e-05	0.00205	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—SLIT2—epilepsy syndrome	3.55e-05	0.00205	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—CACNA1D—epilepsy syndrome	3.53e-05	0.00204	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—PRNP—epilepsy syndrome	3.51e-05	0.00203	CbGpPWpGaD
Methsuximide—Ketazolam—GABRD—epilepsy syndrome	3.47e-05	0.0258	CrCbGaD
Methsuximide—CACNA1G—Developmental Biology—DCX—epilepsy syndrome	3.46e-05	0.002	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—CACNA1H—epilepsy syndrome	3.46e-05	0.002	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—CACNA1D—epilepsy syndrome	3.42e-05	0.00198	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—CACNA1D—epilepsy syndrome	3.42e-05	0.00198	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—GDNF—epilepsy syndrome	3.41e-05	0.00197	CbGpPWpGaD
Methsuximide—Glutethimide—CYP11A1—epilepsy syndrome	3.38e-05	0.0251	CrCbGaD
Methsuximide—CACNA1H—Developmental Biology—DCX—epilepsy syndrome	3.35e-05	0.00193	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—GDNF—epilepsy syndrome	3.3e-05	0.00191	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—SPTAN1—epilepsy syndrome	3.3e-05	0.00191	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—GDNF—epilepsy syndrome	3.3e-05	0.00191	CbGpPWpGaD
Methsuximide—Phenytoin—SCN8A—epilepsy syndrome	3.23e-05	0.0239	CrCbGaD
Methsuximide—CACNA1G—Developmental Biology—SCN2A—epilepsy syndrome	3.21e-05	0.00186	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—SPTAN1—epilepsy syndrome	3.2e-05	0.00185	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—SPTAN1—epilepsy syndrome	3.2e-05	0.00185	CbGpPWpGaD
Methsuximide—Glutethimide—GABRB3—epilepsy syndrome	3.2e-05	0.0237	CrCbGaD
Methsuximide—CACNA1H—Developmental Biology—CACNA1G—epilepsy syndrome	3.11e-05	0.0018	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—SCN2A—epilepsy syndrome	3.11e-05	0.0018	CbGpPWpGaD
Methsuximide—CACNA1I—NCAM signaling for neurite out-growth—SRC—epilepsy syndrome	3.09e-05	0.00179	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—ACTB—epilepsy syndrome	3.09e-05	0.00179	CbGpPWpGaD
Methsuximide—Primidone—GRIA2—epilepsy syndrome	3.08e-05	0.0228	CrCbGaD
Methsuximide—CACNA1I—Axon guidance—ITGA2—epilepsy syndrome	3.03e-05	0.00175	CbGpPWpGaD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—PRKCB—epilepsy syndrome	2.95e-05	0.0017	CbGpPWpGaD
Methsuximide—Diarrhoea—Acetazolamide—epilepsy syndrome	2.92e-05	0.000914	CcSEcCtD
Methsuximide—Insomnia—Phenytoin—epilepsy syndrome	2.91e-05	0.000911	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	2.9e-05	0.000908	CcSEcCtD
Methsuximide—Gastrointestinal pain—Diazepam—epilepsy syndrome	2.9e-05	0.000908	CcSEcCtD
Methsuximide—Insomnia—Oxcarbazepine—epilepsy syndrome	2.89e-05	0.000906	CcSEcCtD
Methsuximide—Methylphenobarbital—GRIA2—epilepsy syndrome	2.89e-05	0.0214	CrCbGaD
Methsuximide—Somnolence—Clonazepam—epilepsy syndrome	2.88e-05	0.000901	CcSEcCtD
Methsuximide—Constipation—Zonisamide—epilepsy syndrome	2.87e-05	0.000899	CcSEcCtD
Methsuximide—Ethotoin—SCN1A—epilepsy syndrome	2.87e-05	0.0213	CrCbGaD
Methsuximide—Eosinophilia—Topiramate—epilepsy syndrome	2.86e-05	0.000896	CcSEcCtD
Methsuximide—Urticaria—Vigabatrin—epilepsy syndrome	2.86e-05	0.000896	CcSEcCtD
Methsuximide—Somnolence—Phenytoin—epilepsy syndrome	2.86e-05	0.000895	CcSEcCtD
Methsuximide—CYP2C19—Melatonin metabolism and effects—CYP2D6—epilepsy syndrome	2.86e-05	0.00165	CbGpPWpGaD
Methsuximide—Abdominal pain—Vigabatrin—epilepsy syndrome	2.85e-05	0.000891	CcSEcCtD
Methsuximide—Somnolence—Oxcarbazepine—epilepsy syndrome	2.85e-05	0.00089	CcSEcCtD
Methsuximide—Nausea—Clobazam—epilepsy syndrome	2.84e-05	0.00089	CcSEcCtD
Methsuximide—Erythema multiforme—Pregabalin—epilepsy syndrome	2.84e-05	0.000888	CcSEcCtD
Methsuximide—Tension—Valproic Acid—epilepsy syndrome	2.84e-05	0.000888	CcSEcCtD
Methsuximide—Feeling abnormal—Felbamate—epilepsy syndrome	2.83e-05	0.000886	CcSEcCtD
Methsuximide—Anorexia—Lamotrigine—epilepsy syndrome	2.83e-05	0.000885	CcSEcCtD
Methsuximide—Dizziness—Acetazolamide—epilepsy syndrome	2.82e-05	0.000883	CcSEcCtD
Methsuximide—Urticaria—Diazepam—epilepsy syndrome	2.82e-05	0.000882	CcSEcCtD
Methsuximide—Decreased appetite—Clonazepam—epilepsy syndrome	2.82e-05	0.000881	CcSEcCtD
Methsuximide—Gastrointestinal pain—Felbamate—epilepsy syndrome	2.81e-05	0.000879	CcSEcCtD
Methsuximide—Nervousness—Valproic Acid—epilepsy syndrome	2.81e-05	0.000878	CcSEcCtD
Methsuximide—Abdominal pain—Diazepam—epilepsy syndrome	2.8e-05	0.000878	CcSEcCtD
Methsuximide—Decreased appetite—Phenytoin—epilepsy syndrome	2.8e-05	0.000875	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	2.8e-05	0.000875	CcSEcCtD
Methsuximide—Decreased appetite—Oxcarbazepine—epilepsy syndrome	2.78e-05	0.000871	CcSEcCtD
Methsuximide—Insomnia—Carbamazepine—epilepsy syndrome	2.78e-05	0.000869	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	2.78e-05	0.000869	CcSEcCtD
Methsuximide—Constipation—Clonazepam—epilepsy syndrome	2.77e-05	0.000867	CcSEcCtD
Methsuximide—Feeling abnormal—Zonisamide—epilepsy syndrome	2.77e-05	0.000867	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	2.76e-05	0.000865	CcSEcCtD
Methsuximide—Constipation—Phenytoin—epilepsy syndrome	2.75e-05	0.000861	CcSEcCtD
Methsuximide—Gastrointestinal pain—Zonisamide—epilepsy syndrome	2.75e-05	0.00086	CcSEcCtD
Methsuximide—Pancytopenia—Topiramate—epilepsy syndrome	2.75e-05	0.00086	CcSEcCtD
Methsuximide—Glutethimide—GABRA1—epilepsy syndrome	2.74e-05	0.0204	CrCbGaD
Methsuximide—Constipation—Oxcarbazepine—epilepsy syndrome	2.74e-05	0.000857	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—CNTN2—epilepsy syndrome	2.73e-05	0.00158	CbGpPWpGaD
Methsuximide—Somnolence—Carbamazepine—epilepsy syndrome	2.73e-05	0.000854	CcSEcCtD
Methsuximide—Urticaria—Felbamate—epilepsy syndrome	2.73e-05	0.000854	CcSEcCtD
Methsuximide—Vision blurred—Valproic Acid—epilepsy syndrome	2.72e-05	0.000852	CcSEcCtD
Methsuximide—Abdominal pain—Felbamate—epilepsy syndrome	2.71e-05	0.000849	CcSEcCtD
Methsuximide—Vomiting—Acetazolamide—epilepsy syndrome	2.71e-05	0.000849	CcSEcCtD
Methsuximide—Diarrhoea—Propofol—epilepsy syndrome	2.71e-05	0.000849	CcSEcCtD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—FOS—epilepsy syndrome	2.69e-05	0.00155	CbGpPWpGaD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—POMC—epilepsy syndrome	2.69e-05	0.00155	CbGpPWpGaD
Methsuximide—Insomnia—Lamotrigine—epilepsy syndrome	2.68e-05	0.00084	CcSEcCtD
Methsuximide—Headache—Acetazolamide—epilepsy syndrome	2.67e-05	0.000837	CcSEcCtD
Methsuximide—Urticaria—Zonisamide—epilepsy syndrome	2.67e-05	0.000836	CcSEcCtD
Methsuximide—Decreased appetite—Carbamazepine—epilepsy syndrome	2.67e-05	0.000836	CcSEcCtD
Methsuximide—Feeling abnormal—Clonazepam—epilepsy syndrome	2.67e-05	0.000835	CcSEcCtD
Methsuximide—Abdominal pain—Zonisamide—epilepsy syndrome	2.66e-05	0.000831	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	2.65e-05	0.00083	CcSEcCtD
Methsuximide—Feeling abnormal—Phenytoin—epilepsy syndrome	2.65e-05	0.00083	CcSEcCtD
Methsuximide—Gastrointestinal pain—Clonazepam—epilepsy syndrome	2.65e-05	0.000829	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—CNTN2—epilepsy syndrome	2.65e-05	0.00153	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—TCF4—epilepsy syndrome	2.64e-05	0.00153	CbGpPWpGaD
Methsuximide—Somnolence—Lamotrigine—epilepsy syndrome	2.64e-05	0.000826	CcSEcCtD
Methsuximide—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	2.64e-05	0.000825	CcSEcCtD
Methsuximide—Constipation—Carbamazepine—epilepsy syndrome	2.63e-05	0.000822	CcSEcCtD
Methsuximide—Pethidine—GRIN2A—epilepsy syndrome	2.63e-05	0.0195	CrCbGaD
Methsuximide—Dizziness—Propofol—epilepsy syndrome	2.62e-05	0.00082	CcSEcCtD
Methsuximide—Diarrhoea—Levetiracetam—epilepsy syndrome	2.62e-05	0.00082	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—ANK3—epilepsy syndrome	2.62e-05	0.00151	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—SLIT2—epilepsy syndrome	2.62e-05	0.00151	CbGpPWpGaD
Methsuximide—Weight decreased—Topiramate—epilepsy syndrome	2.62e-05	0.000819	CcSEcCtD
Methsuximide—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	2.62e-05	0.000819	CcSEcCtD
Methsuximide—Phenytoin—SCN9A—epilepsy syndrome	2.61e-05	0.0194	CrCbGaD
Methsuximide—Erythema multiforme—Gabapentin—epilepsy syndrome	2.6e-05	0.000814	CcSEcCtD
Methsuximide—CACNA1I—Axon guidance—DLG4—epilepsy syndrome	2.59e-05	0.0015	CbGpPWpGaD
Methsuximide—Leukopenia—Valproic Acid—epilepsy syndrome	2.59e-05	0.00081	CcSEcCtD
Methsuximide—CACNA1G—Axon guidance—PRNP—epilepsy syndrome	2.59e-05	0.00149	CbGpPWpGaD
Methsuximide—Decreased appetite—Lamotrigine—epilepsy syndrome	2.58e-05	0.000808	CcSEcCtD
Methsuximide—Primidone—GABRG2—epilepsy syndrome	2.58e-05	0.0191	CrCbGaD
Methsuximide—Urticaria—Clonazepam—epilepsy syndrome	2.57e-05	0.000805	CcSEcCtD
Methsuximide—Dizziness—Midazolam—epilepsy syndrome	2.56e-05	0.000803	CcSEcCtD
Methsuximide—Tension—Pregabalin—epilepsy syndrome	2.56e-05	0.000802	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	2.56e-05	0.000802	CcSEcCtD
Methsuximide—Abdominal pain—Clonazepam—epilepsy syndrome	2.56e-05	0.000801	CcSEcCtD
Methsuximide—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	2.56e-05	0.0008	CcSEcCtD
Methsuximide—Urticaria—Phenytoin—epilepsy syndrome	2.56e-05	0.0008	CcSEcCtD
Methsuximide—Urticaria—Oxcarbazepine—epilepsy syndrome	2.54e-05	0.000796	CcSEcCtD
Methsuximide—Constipation—Lamotrigine—epilepsy syndrome	2.54e-05	0.000794	CcSEcCtD
Methsuximide—Nervousness—Pregabalin—epilepsy syndrome	2.54e-05	0.000794	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—SLIT2—epilepsy syndrome	2.54e-05	0.00147	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—ANK3—epilepsy syndrome	2.54e-05	0.00147	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—GRIN2B—epilepsy syndrome	2.54e-05	0.00147	CbGpPWpGaD
Methsuximide—Nausea—Acetazolamide—epilepsy syndrome	2.54e-05	0.000793	CcSEcCtD
Methsuximide—Ethotoin—SCN2A—epilepsy syndrome	2.53e-05	0.0188	CrCbGaD
Methsuximide—Dizziness—Levetiracetam—epilepsy syndrome	2.53e-05	0.000793	CcSEcCtD
Methsuximide—Feeling abnormal—Carbamazepine—epilepsy syndrome	2.53e-05	0.000792	CcSEcCtD
Methsuximide—Abdominal pain—Oxcarbazepine—epilepsy syndrome	2.53e-05	0.000792	CcSEcCtD
Methsuximide—Diarrhoea—Fosphenytoin—epilepsy syndrome	2.53e-05	0.000792	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—CACNA1D—epilepsy syndrome	2.52e-05	0.00146	CbGpPWpGaD
Methsuximide—Vomiting—Propofol—epilepsy syndrome	2.52e-05	0.000789	CcSEcCtD
Methsuximide—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	2.51e-05	0.000786	CcSEcCtD
Methsuximide—CACNA1H—Axon guidance—PRNP—epilepsy syndrome	2.5e-05	0.00145	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—PRNP—epilepsy syndrome	2.5e-05	0.00145	CbGpPWpGaD
Methsuximide—Rash—Propofol—epilepsy syndrome	2.5e-05	0.000782	CcSEcCtD
Methsuximide—Dermatitis—Propofol—epilepsy syndrome	2.5e-05	0.000782	CcSEcCtD
Methsuximide—Phenytoin—SCN3A—epilepsy syndrome	2.5e-05	0.0185	CrCbGaD
Methsuximide—Headache—Propofol—epilepsy syndrome	2.48e-05	0.000777	CcSEcCtD
Methsuximide—Vomiting—Midazolam—epilepsy syndrome	2.47e-05	0.000772	CcSEcCtD
Methsuximide—Diarrhoea—Vigabatrin—epilepsy syndrome	2.47e-05	0.000772	CcSEcCtD
Methsuximide—Vision blurred—Pregabalin—epilepsy syndrome	2.46e-05	0.000771	CcSEcCtD
Methsuximide—Haematuria—Topiramate—epilepsy syndrome	2.46e-05	0.00077	CcSEcCtD
Methsuximide—Feeling abnormal—Lamotrigine—epilepsy syndrome	2.45e-05	0.000765	CcSEcCtD
Methsuximide—Rash—Midazolam—epilepsy syndrome	2.45e-05	0.000765	CcSEcCtD
Methsuximide—Dizziness—Fosphenytoin—epilepsy syndrome	2.44e-05	0.000765	CcSEcCtD
Methsuximide—Dermatitis—Midazolam—epilepsy syndrome	2.44e-05	0.000765	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—CACNA1D—epilepsy syndrome	2.44e-05	0.00141	CbGpPWpGaD
Methsuximide—Urticaria—Carbamazepine—epilepsy syndrome	2.44e-05	0.000764	CcSEcCtD
Methsuximide—Vomiting—Levetiracetam—epilepsy syndrome	2.44e-05	0.000762	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—GDNF—epilepsy syndrome	2.44e-05	0.00141	CbGpPWpGaD
Methsuximide—Headache—Midazolam—epilepsy syndrome	2.43e-05	0.00076	CcSEcCtD
Methsuximide—Abdominal pain—Carbamazepine—epilepsy syndrome	2.43e-05	0.00076	CcSEcCtD
Methsuximide—Diarrhoea—Diazepam—epilepsy syndrome	2.43e-05	0.00076	CcSEcCtD
Methsuximide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	2.43e-05	0.00076	CcSEcCtD
Methsuximide—Rash—Levetiracetam—epilepsy syndrome	2.41e-05	0.000756	CcSEcCtD
Methsuximide—Dermatitis—Levetiracetam—epilepsy syndrome	2.41e-05	0.000755	CcSEcCtD
Methsuximide—Headache—Levetiracetam—epilepsy syndrome	2.4e-05	0.000751	CcSEcCtD
Methsuximide—Phenytoin—SCN4A—epilepsy syndrome	2.4e-05	0.0178	CrCbGaD
Methsuximide—Dizziness—Vigabatrin—epilepsy syndrome	2.38e-05	0.000746	CcSEcCtD
Methsuximide—Confusional state—Valproic Acid—epilepsy syndrome	2.38e-05	0.000744	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—GDNF—epilepsy syndrome	2.36e-05	0.00136	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—SPTAN1—epilepsy syndrome	2.36e-05	0.00136	CbGpPWpGaD
Methsuximide—Urticaria—Lamotrigine—epilepsy syndrome	2.36e-05	0.000738	CcSEcCtD
Methsuximide—Nausea—Propofol—epilepsy syndrome	2.35e-05	0.000737	CcSEcCtD
Methsuximide—CACNA1I—Developmental Biology—CDH2—epilepsy syndrome	2.35e-05	0.00136	CbGpPWpGaD
Methsuximide—Tension—Gabapentin—epilepsy syndrome	2.35e-05	0.000736	CcSEcCtD
Methsuximide—Vomiting—Fosphenytoin—epilepsy syndrome	2.35e-05	0.000736	CcSEcCtD
Methsuximide—Diarrhoea—Felbamate—epilepsy syndrome	2.35e-05	0.000735	CcSEcCtD
Methsuximide—Abdominal pain—Lamotrigine—epilepsy syndrome	2.35e-05	0.000734	CcSEcCtD
Methsuximide—Dizziness—Diazepam—epilepsy syndrome	2.35e-05	0.000734	CcSEcCtD
Methsuximide—Leukopenia—Pregabalin—epilepsy syndrome	2.34e-05	0.000732	CcSEcCtD
Methsuximide—Rash—Fosphenytoin—epilepsy syndrome	2.33e-05	0.000729	CcSEcCtD
Methsuximide—Dermatitis—Fosphenytoin—epilepsy syndrome	2.33e-05	0.000729	CcSEcCtD
Methsuximide—Nervousness—Gabapentin—epilepsy syndrome	2.33e-05	0.000728	CcSEcCtD
Methsuximide—Headache—Fosphenytoin—epilepsy syndrome	2.32e-05	0.000725	CcSEcCtD
Methsuximide—Nausea—Midazolam—epilepsy syndrome	2.3e-05	0.000721	CcSEcCtD
Methsuximide—Diarrhoea—Zonisamide—epilepsy syndrome	2.3e-05	0.00072	CcSEcCtD
Methsuximide—CYP2C19—Metapathway biotransformation—KCNAB2—epilepsy syndrome	2.29e-05	0.00133	CbGpPWpGaD
Methsuximide—Vomiting—Vigabatrin—epilepsy syndrome	2.29e-05	0.000717	CcSEcCtD
Methsuximide—CACNA1I—Axon guidance—ADAM10—epilepsy syndrome	2.29e-05	0.00132	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—SPTAN1—epilepsy syndrome	2.28e-05	0.00132	CbGpPWpGaD
Methsuximide—CACNA1G—NCAM signaling for neurite out-growth—SRC—epilepsy syndrome	2.28e-05	0.00132	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—ACTB—epilepsy syndrome	2.28e-05	0.00132	CbGpPWpGaD
Methsuximide—Nausea—Levetiracetam—epilepsy syndrome	2.28e-05	0.000712	CcSEcCtD
Methsuximide—Rash—Vigabatrin—epilepsy syndrome	2.27e-05	0.000711	CcSEcCtD
Methsuximide—Dizziness—Felbamate—epilepsy syndrome	2.27e-05	0.000711	CcSEcCtD
Methsuximide—Dermatitis—Vigabatrin—epilepsy syndrome	2.27e-05	0.00071	CcSEcCtD
Methsuximide—Vision blurred—Gabapentin—epilepsy syndrome	2.26e-05	0.000707	CcSEcCtD
Methsuximide—Headache—Vigabatrin—epilepsy syndrome	2.26e-05	0.000706	CcSEcCtD
Methsuximide—Vomiting—Diazepam—epilepsy syndrome	2.26e-05	0.000706	CcSEcCtD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—BCL2—epilepsy syndrome	2.26e-05	0.0013	CbGpPWpGaD
Methsuximide—Anorexia—Valproic Acid—epilepsy syndrome	2.25e-05	0.000704	CcSEcCtD
Methsuximide—CACNA1G—Axon guidance—ITGA2—epilepsy syndrome	2.24e-05	0.00129	CbGpPWpGaD
Methsuximide—Rash—Diazepam—epilepsy syndrome	2.24e-05	0.0007	CcSEcCtD
Methsuximide—Dermatitis—Diazepam—epilepsy syndrome	2.23e-05	0.000699	CcSEcCtD
Methsuximide—Pethidine—GRIN2B—epilepsy syndrome	2.23e-05	0.0166	CrCbGaD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—epilepsy syndrome	2.23e-05	0.00129	CbGpPWpGaD
Methsuximide—Dizziness—Zonisamide—epilepsy syndrome	2.22e-05	0.000696	CcSEcCtD
Methsuximide—Headache—Diazepam—epilepsy syndrome	2.22e-05	0.000696	CcSEcCtD
Methsuximide—Diarrhoea—Clonazepam—epilepsy syndrome	2.22e-05	0.000694	CcSEcCtD
Methsuximide—CACNA1H—NCAM signaling for neurite out-growth—SRC—epilepsy syndrome	2.21e-05	0.00128	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—ACTB—epilepsy syndrome	2.21e-05	0.00127	CbGpPWpGaD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—RELA—epilepsy syndrome	2.2e-05	0.00127	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—ACTB—epilepsy syndrome	2.2e-05	0.00127	CbGpPWpGaD
Methsuximide—Diarrhoea—Phenytoin—epilepsy syndrome	2.2e-05	0.000689	CcSEcCtD
Methsuximide—Nausea—Fosphenytoin—epilepsy syndrome	2.2e-05	0.000687	CcSEcCtD
Methsuximide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.19e-05	0.000685	CcSEcCtD
Methsuximide—Erythema multiforme—Topiramate—epilepsy syndrome	2.19e-05	0.000685	CcSEcCtD
Methsuximide—Vomiting—Felbamate—epilepsy syndrome	2.18e-05	0.000683	CcSEcCtD
Methsuximide—Primidone—CHRNA7—epilepsy syndrome	2.18e-05	0.0162	CrCbGaD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—epilepsy syndrome	2.17e-05	0.00125	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—ITGA2—epilepsy syndrome	2.17e-05	0.00125	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—ITGA2—epilepsy syndrome	2.17e-05	0.00125	CbGpPWpGaD
Methsuximide—Rash—Felbamate—epilepsy syndrome	2.16e-05	0.000678	CcSEcCtD
Methsuximide—Dermatitis—Felbamate—epilepsy syndrome	2.16e-05	0.000677	CcSEcCtD
Methsuximide—Headache—Felbamate—epilepsy syndrome	2.15e-05	0.000673	CcSEcCtD
Methsuximide—Confusional state—Pregabalin—epilepsy syndrome	2.15e-05	0.000673	CcSEcCtD
Methsuximide—Leukopenia—Gabapentin—epilepsy syndrome	2.14e-05	0.000671	CcSEcCtD
Methsuximide—Dizziness—Clonazepam—epilepsy syndrome	2.14e-05	0.00067	CcSEcCtD
Methsuximide—Nausea—Vigabatrin—epilepsy syndrome	2.14e-05	0.00067	CcSEcCtD
Methsuximide—Vomiting—Zonisamide—epilepsy syndrome	2.14e-05	0.000669	CcSEcCtD
Methsuximide—CACNA1I—Axon guidance—CDC42—epilepsy syndrome	2.14e-05	0.00123	CbGpPWpGaD
Methsuximide—Insomnia—Valproic Acid—epilepsy syndrome	2.13e-05	0.000668	CcSEcCtD
Methsuximide—Dizziness—Phenytoin—epilepsy syndrome	2.13e-05	0.000666	CcSEcCtD
Methsuximide—Rash—Zonisamide—epilepsy syndrome	2.12e-05	0.000663	CcSEcCtD
Methsuximide—Dermatitis—Zonisamide—epilepsy syndrome	2.12e-05	0.000663	CcSEcCtD
Methsuximide—Dizziness—Oxcarbazepine—epilepsy syndrome	2.12e-05	0.000662	CcSEcCtD
Methsuximide—Nausea—Diazepam—epilepsy syndrome	2.11e-05	0.000659	CcSEcCtD
Methsuximide—Headache—Zonisamide—epilepsy syndrome	2.11e-05	0.000659	CcSEcCtD
Methsuximide—Diarrhoea—Carbamazepine—epilepsy syndrome	2.1e-05	0.000658	CcSEcCtD
Methsuximide—Somnolence—Valproic Acid—epilepsy syndrome	2.1e-05	0.000656	CcSEcCtD
Methsuximide—Primidone—GABRA5—epilepsy syndrome	2.07e-05	0.0154	CrCbGaD
Methsuximide—Vomiting—Clonazepam—epilepsy syndrome	2.06e-05	0.000645	CcSEcCtD
Methsuximide—Decreased appetite—Valproic Acid—epilepsy syndrome	2.05e-05	0.000642	CcSEcCtD
Methsuximide—Vomiting—Phenytoin—epilepsy syndrome	2.05e-05	0.00064	CcSEcCtD
Methsuximide—Methylphenobarbital—CHRNA7—epilepsy syndrome	2.04e-05	0.0152	CrCbGaD
Methsuximide—Rash—Clonazepam—epilepsy syndrome	2.04e-05	0.000639	CcSEcCtD
Methsuximide—Dermatitis—Clonazepam—epilepsy syndrome	2.04e-05	0.000639	CcSEcCtD
Methsuximide—Nausea—Felbamate—epilepsy syndrome	2.04e-05	0.000638	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.04e-05	0.000637	CcSEcCtD
Methsuximide—Primidone—GRIK2—epilepsy syndrome	2.04e-05	0.0151	CrCbGaD
Methsuximide—Vomiting—Oxcarbazepine—epilepsy syndrome	2.03e-05	0.000637	CcSEcCtD
Methsuximide—Anorexia—Pregabalin—epilepsy syndrome	2.03e-05	0.000636	CcSEcCtD
Methsuximide—Dizziness—Carbamazepine—epilepsy syndrome	2.03e-05	0.000636	CcSEcCtD
Methsuximide—Diarrhoea—Lamotrigine—epilepsy syndrome	2.03e-05	0.000636	CcSEcCtD
Methsuximide—Headache—Clonazepam—epilepsy syndrome	2.03e-05	0.000635	CcSEcCtD
Methsuximide—Rash—Phenytoin—epilepsy syndrome	2.03e-05	0.000635	CcSEcCtD
Methsuximide—Dermatitis—Phenytoin—epilepsy syndrome	2.03e-05	0.000634	CcSEcCtD
Methsuximide—Rash—Oxcarbazepine—epilepsy syndrome	2.02e-05	0.000632	CcSEcCtD
Methsuximide—Constipation—Valproic Acid—epilepsy syndrome	2.02e-05	0.000631	CcSEcCtD
Methsuximide—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.02e-05	0.000631	CcSEcCtD
Methsuximide—Headache—Phenytoin—epilepsy syndrome	2.02e-05	0.000631	CcSEcCtD
Methsuximide—Headache—Oxcarbazepine—epilepsy syndrome	2e-05	0.000627	CcSEcCtD
Methsuximide—Nausea—Zonisamide—epilepsy syndrome	2e-05	0.000625	CcSEcCtD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—CASP3—epilepsy syndrome	1.99e-05	0.00115	CbGpPWpGaD
Methsuximide—Tension—Topiramate—epilepsy syndrome	1.98e-05	0.000619	CcSEcCtD
Methsuximide—Confusional state—Gabapentin—epilepsy syndrome	1.97e-05	0.000617	CcSEcCtD
Methsuximide—Dizziness—Lamotrigine—epilepsy syndrome	1.96e-05	0.000614	CcSEcCtD
Methsuximide—Nervousness—Topiramate—epilepsy syndrome	1.96e-05	0.000613	CcSEcCtD
Methsuximide—Vomiting—Carbamazepine—epilepsy syndrome	1.95e-05	0.000611	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—TCF4—epilepsy syndrome	1.95e-05	0.00113	CbGpPWpGaD
Methsuximide—Methylphenobarbital—GABRA5—epilepsy syndrome	1.94e-05	0.0144	CrCbGaD
Methsuximide—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.94e-05	0.000608	CcSEcCtD
Methsuximide—Phenobarbital—GRIA2—epilepsy syndrome	1.94e-05	0.0144	CrCbGaD
Methsuximide—Rash—Carbamazepine—epilepsy syndrome	1.94e-05	0.000606	CcSEcCtD
Methsuximide—Dermatitis—Carbamazepine—epilepsy syndrome	1.93e-05	0.000605	CcSEcCtD
Methsuximide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.93e-05	0.000604	CcSEcCtD
Methsuximide—Insomnia—Pregabalin—epilepsy syndrome	1.93e-05	0.000604	CcSEcCtD
Methsuximide—Nausea—Clonazepam—epilepsy syndrome	1.92e-05	0.000602	CcSEcCtD
Methsuximide—Headache—Carbamazepine—epilepsy syndrome	1.92e-05	0.000602	CcSEcCtD
Methsuximide—CACNA1G—Axon guidance—DLG4—epilepsy syndrome	1.91e-05	0.00111	CbGpPWpGaD
Methsuximide—Nausea—Phenytoin—epilepsy syndrome	1.91e-05	0.000598	CcSEcCtD
Methsuximide—Methylphenobarbital—GRIK2—epilepsy syndrome	1.91e-05	0.0142	CrCbGaD
Methsuximide—CACNA1I—Axon guidance—FYN—epilepsy syndrome	1.9e-05	0.0011	CbGpPWpGaD
Methsuximide—Nausea—Oxcarbazepine—epilepsy syndrome	1.9e-05	0.000595	CcSEcCtD
Methsuximide—Vision blurred—Topiramate—epilepsy syndrome	1.9e-05	0.000594	CcSEcCtD
Methsuximide—Somnolence—Pregabalin—epilepsy syndrome	1.9e-05	0.000593	CcSEcCtD
Methsuximide—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	1.89e-05	0.00109	CbGpPWpGaD
Methsuximide—Vomiting—Lamotrigine—epilepsy syndrome	1.89e-05	0.000591	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—TCF4—epilepsy syndrome	1.89e-05	0.00109	CbGpPWpGaD
Methsuximide—Urticaria—Valproic Acid—epilepsy syndrome	1.87e-05	0.000586	CcSEcCtD
Methsuximide—Rash—Lamotrigine—epilepsy syndrome	1.87e-05	0.000586	CcSEcCtD
Methsuximide—CACNA1G—Axon guidance—GRIN2B—epilepsy syndrome	1.87e-05	0.00108	CbGpPWpGaD
Methsuximide—Dermatitis—Lamotrigine—epilepsy syndrome	1.87e-05	0.000585	CcSEcCtD
Methsuximide—Abdominal pain—Valproic Acid—epilepsy syndrome	1.86e-05	0.000584	CcSEcCtD
Methsuximide—Anorexia—Gabapentin—epilepsy syndrome	1.86e-05	0.000583	CcSEcCtD
Methsuximide—Clobazam—GABRG2—epilepsy syndrome	1.86e-05	0.0138	CrCbGaD
Methsuximide—Headache—Lamotrigine—epilepsy syndrome	1.86e-05	0.000582	CcSEcCtD
Methsuximide—Decreased appetite—Pregabalin—epilepsy syndrome	1.85e-05	0.00058	CcSEcCtD
Methsuximide—CACNA1H—Axon guidance—DLG4—epilepsy syndrome	1.85e-05	0.00107	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—DLG4—epilepsy syndrome	1.85e-05	0.00107	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—PRNP—epilepsy syndrome	1.85e-05	0.00107	CbGpPWpGaD
Methsuximide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.84e-05	0.000576	CcSEcCtD
Methsuximide—Nausea—Carbamazepine—epilepsy syndrome	1.82e-05	0.000571	CcSEcCtD
Methsuximide—Constipation—Pregabalin—epilepsy syndrome	1.82e-05	0.000571	CcSEcCtD
Methsuximide—Ketazolam—GABRA1—epilepsy syndrome	1.82e-05	0.0135	CrCbGaD
Methsuximide—Primidone—GABRB2—epilepsy syndrome	1.81e-05	0.0135	CrCbGaD
Methsuximide—CACNA1H—Axon guidance—GRIN2B—epilepsy syndrome	1.81e-05	0.00105	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—GRIN2B—epilepsy syndrome	1.81e-05	0.00105	CbGpPWpGaD
Methsuximide—Leukopenia—Topiramate—epilepsy syndrome	1.8e-05	0.000565	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—PRNP—epilepsy syndrome	1.79e-05	0.00103	CbGpPWpGaD
Methsuximide—Primidone—GABRA1—epilepsy syndrome	1.78e-05	0.0132	CrCbGaD
Methsuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP11A1—epilepsy syndrome	1.77e-05	0.00102	CbGpPWpGaD
Methsuximide—Insomnia—Gabapentin—epilepsy syndrome	1.77e-05	0.000553	CcSEcCtD
Methsuximide—Nausea—Lamotrigine—epilepsy syndrome	1.76e-05	0.000552	CcSEcCtD
Methsuximide—Feeling abnormal—Pregabalin—epilepsy syndrome	1.76e-05	0.00055	CcSEcCtD
Methsuximide—Phenytoin—SCN1A—epilepsy syndrome	1.75e-05	0.013	CrCbGaD
Methsuximide—CYP2C19—Oxidation by Cytochrome P450—CYP11A1—epilepsy syndrome	1.75e-05	0.00101	CbGpPWpGaD
Methsuximide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.74e-05	0.000546	CcSEcCtD
Methsuximide—Primidone—CHRNA4—epilepsy syndrome	1.74e-05	0.0129	CrCbGaD
Methsuximide—Somnolence—Gabapentin—epilepsy syndrome	1.74e-05	0.000544	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—CDH2—epilepsy syndrome	1.74e-05	0.001	CbGpPWpGaD
Methsuximide—Aminophenazone—CYP2C19—epilepsy syndrome	1.72e-05	0.0127	CrCbGaD
Methsuximide—Decreased appetite—Gabapentin—epilepsy syndrome	1.7e-05	0.000532	CcSEcCtD
Methsuximide—Urticaria—Pregabalin—epilepsy syndrome	1.69e-05	0.00053	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.69e-05	0.000528	CcSEcCtD
Methsuximide—Abdominal pain—Pregabalin—epilepsy syndrome	1.69e-05	0.000528	CcSEcCtD
Methsuximide—CACNA1G—Axon guidance—ADAM10—epilepsy syndrome	1.69e-05	0.000974	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—CDH2—epilepsy syndrome	1.68e-05	0.000971	CbGpPWpGaD
Methsuximide—Constipation—Gabapentin—epilepsy syndrome	1.67e-05	0.000523	CcSEcCtD
Methsuximide—CACNA1I—Developmental Biology—AKT3—epilepsy syndrome	1.67e-05	0.000965	CbGpPWpGaD
Methsuximide—Methylphenobarbital—GABRA1—epilepsy syndrome	1.67e-05	0.0124	CrCbGaD
Methsuximide—Confusional state—Topiramate—epilepsy syndrome	1.66e-05	0.000519	CcSEcCtD
Methsuximide—Methylphenobarbital—CHRNA4—epilepsy syndrome	1.63e-05	0.0121	CrCbGaD
Methsuximide—CACNA1H—Axon guidance—ADAM10—epilepsy syndrome	1.63e-05	0.000944	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—ADAM10—epilepsy syndrome	1.63e-05	0.000943	CbGpPWpGaD
Methsuximide—CYP2C19—Melatonin metabolism and effects—APOE—epilepsy syndrome	1.63e-05	0.000943	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—ACTB—epilepsy syndrome	1.62e-05	0.000939	CbGpPWpGaD
Methsuximide—Diarrhoea—Valproic Acid—epilepsy syndrome	1.61e-05	0.000505	CcSEcCtD
Methsuximide—Feeling abnormal—Gabapentin—epilepsy syndrome	1.61e-05	0.000504	CcSEcCtD
Methsuximide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.6e-05	0.0005	CcSEcCtD
Methsuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—epilepsy syndrome	1.6e-05	0.000924	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—ITGA2—epilepsy syndrome	1.6e-05	0.000923	CbGpPWpGaD
Methsuximide—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—epilepsy syndrome	1.58e-05	0.000912	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—CDC42—epilepsy syndrome	1.57e-05	0.00091	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—ACTB—epilepsy syndrome	1.57e-05	0.00091	CbGpPWpGaD
Methsuximide—Anorexia—Topiramate—epilepsy syndrome	1.57e-05	0.000491	CcSEcCtD
Methsuximide—CACNA1I—Axon guidance—KDR—epilepsy syndrome	1.57e-05	0.000906	CbGpPWpGaD
Methsuximide—Dizziness—Valproic Acid—epilepsy syndrome	1.56e-05	0.000488	CcSEcCtD
Methsuximide—Urticaria—Gabapentin—epilepsy syndrome	1.55e-05	0.000486	CcSEcCtD
Methsuximide—Phenytoin—SCN2A—epilepsy syndrome	1.55e-05	0.0115	CrCbGaD
Methsuximide—CACNA1H—Developmental Biology—ITGA2—epilepsy syndrome	1.55e-05	0.000894	CbGpPWpGaD
Methsuximide—Abdominal pain—Gabapentin—epilepsy syndrome	1.55e-05	0.000484	CcSEcCtD
Methsuximide—CACNA1H—Axon guidance—CDC42—epilepsy syndrome	1.52e-05	0.000881	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—CDC42—epilepsy syndrome	1.52e-05	0.000881	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—IL6ST—epilepsy syndrome	1.5e-05	0.000868	CbGpPWpGaD
Methsuximide—Vomiting—Valproic Acid—epilepsy syndrome	1.5e-05	0.000469	CcSEcCtD
Methsuximide—Insomnia—Topiramate—epilepsy syndrome	1.49e-05	0.000466	CcSEcCtD
Methsuximide—Rash—Valproic Acid—epilepsy syndrome	1.49e-05	0.000465	CcSEcCtD
Methsuximide—Dermatitis—Valproic Acid—epilepsy syndrome	1.49e-05	0.000465	CcSEcCtD
Methsuximide—Headache—Valproic Acid—epilepsy syndrome	1.48e-05	0.000462	CcSEcCtD
Methsuximide—Somnolence—Topiramate—epilepsy syndrome	1.46e-05	0.000458	CcSEcCtD
Methsuximide—Diarrhoea—Pregabalin—epilepsy syndrome	1.46e-05	0.000457	CcSEcCtD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	1.44e-05	0.00083	CbGpPWpGaD
Methsuximide—Pethidine—OPRM1—epilepsy syndrome	1.43e-05	0.0106	CrCbGaD
Methsuximide—Decreased appetite—Topiramate—epilepsy syndrome	1.43e-05	0.000448	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.42e-05	0.000444	CcSEcCtD
Methsuximide—Dizziness—Pregabalin—epilepsy syndrome	1.41e-05	0.000441	CcSEcCtD
Methsuximide—Constipation—Topiramate—epilepsy syndrome	1.41e-05	0.00044	CcSEcCtD
Methsuximide—CACNA1G—Axon guidance—FYN—epilepsy syndrome	1.4e-05	0.00081	CbGpPWpGaD
Methsuximide—Nausea—Valproic Acid—epilepsy syndrome	1.4e-05	0.000438	CcSEcCtD
Methsuximide—CACNA1I—Developmental Biology—HES1—epilepsy syndrome	1.4e-05	0.000806	CbGpPWpGaD
Methsuximide—Phenobarbital—CHRNA7—epilepsy syndrome	1.38e-05	0.0102	CrCbGaD
Methsuximide—CACNA1G—Developmental Biology—DLG4—epilepsy syndrome	1.37e-05	0.000789	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—FYN—epilepsy syndrome	1.36e-05	0.000785	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—FYN—epilepsy syndrome	1.36e-05	0.000784	CbGpPWpGaD
Methsuximide—Vomiting—Pregabalin—epilepsy syndrome	1.36e-05	0.000424	CcSEcCtD
Methsuximide—Feeling abnormal—Topiramate—epilepsy syndrome	1.36e-05	0.000424	CcSEcCtD
Methsuximide—CACNA1I—Developmental Biology—MEF2C—epilepsy syndrome	1.35e-05	0.00078	CbGpPWpGaD
Methsuximide—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.35e-05	0.000421	CcSEcCtD
Methsuximide—Rash—Pregabalin—epilepsy syndrome	1.34e-05	0.000421	CcSEcCtD
Methsuximide—Dermatitis—Pregabalin—epilepsy syndrome	1.34e-05	0.00042	CcSEcCtD
Methsuximide—Diarrhoea—Gabapentin—epilepsy syndrome	1.34e-05	0.000419	CcSEcCtD
Methsuximide—Headache—Pregabalin—epilepsy syndrome	1.34e-05	0.000418	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—GRIN2B—epilepsy syndrome	1.33e-05	0.000771	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—DLG4—epilepsy syndrome	1.32e-05	0.000764	CbGpPWpGaD
Methsuximide—Clobazam—GABRB2—epilepsy syndrome	1.31e-05	0.00972	CrCbGaD
Methsuximide—Urticaria—Topiramate—epilepsy syndrome	1.31e-05	0.000409	CcSEcCtD
Methsuximide—Abdominal pain—Topiramate—epilepsy syndrome	1.3e-05	0.000407	CcSEcCtD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	1.3e-05	0.000749	CbGpPWpGaD
Methsuximide—Dizziness—Gabapentin—epilepsy syndrome	1.29e-05	0.000405	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—GRIN2B—epilepsy syndrome	1.29e-05	0.000747	CbGpPWpGaD
Methsuximide—Phenobarbital—GRIK2—epilepsy syndrome	1.29e-05	0.00953	CrCbGaD
Methsuximide—Clobazam—GABRA1—epilepsy syndrome	1.29e-05	0.00953	CrCbGaD
Methsuximide—Aminophenazone—CYP2D6—epilepsy syndrome	1.27e-05	0.00945	CrCbGaD
Methsuximide—Nausea—Pregabalin—epilepsy syndrome	1.27e-05	0.000396	CcSEcCtD
Methsuximide—Vomiting—Gabapentin—epilepsy syndrome	1.24e-05	0.000389	CcSEcCtD
Methsuximide—Rash—Gabapentin—epilepsy syndrome	1.23e-05	0.000386	CcSEcCtD
Methsuximide—Dermatitis—Gabapentin—epilepsy syndrome	1.23e-05	0.000385	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—AKT3—epilepsy syndrome	1.23e-05	0.000712	CbGpPWpGaD
Methsuximide—CYP2C19—Arachidonic acid metabolism—GPX1—epilepsy syndrome	1.23e-05	0.00071	CbGpPWpGaD
Methsuximide—Headache—Gabapentin—epilepsy syndrome	1.22e-05	0.000383	CcSEcCtD
Methsuximide—Phensuximide—CYP2C19—epilepsy syndrome	1.22e-05	0.00903	CrCbGaD
Methsuximide—CACNA1G—Developmental Biology—ADAM10—epilepsy syndrome	1.2e-05	0.000695	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—AKT3—epilepsy syndrome	1.19e-05	0.000689	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—ADAM10—epilepsy syndrome	1.16e-05	0.000673	CbGpPWpGaD
Methsuximide—Nausea—Gabapentin—epilepsy syndrome	1.16e-05	0.000363	CcSEcCtD
Methsuximide—CACNA1G—Axon guidance—KDR—epilepsy syndrome	1.16e-05	0.000668	CbGpPWpGaD
Methsuximide—Diarrhoea—Topiramate—epilepsy syndrome	1.13e-05	0.000352	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—CDC42—epilepsy syndrome	1.12e-05	0.000649	CbGpPWpGaD
Methsuximide—Phenobarbital—GABRA1—epilepsy syndrome	1.12e-05	0.00833	CrCbGaD
Methsuximide—CACNA1H—Axon guidance—KDR—epilepsy syndrome	1.12e-05	0.000647	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—KDR—epilepsy syndrome	1.12e-05	0.000646	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—IL6ST—epilepsy syndrome	1.11e-05	0.00064	CbGpPWpGaD
Methsuximide—Phenobarbital—CHRNA4—epilepsy syndrome	1.1e-05	0.00816	CrCbGaD
Methsuximide—CACNA1H—Developmental Biology—CDC42—epilepsy syndrome	1.09e-05	0.000629	CbGpPWpGaD
Methsuximide—Dizziness—Topiramate—epilepsy syndrome	1.09e-05	0.00034	CcSEcCtD
Methsuximide—Antipyrine—CYP2C19—epilepsy syndrome	1.08e-05	0.00802	CrCbGaD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—AKT1—epilepsy syndrome	1.08e-05	0.000622	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—IL6ST—epilepsy syndrome	1.07e-05	0.00062	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—IL6ST—epilepsy syndrome	1.07e-05	0.00062	CbGpPWpGaD
Methsuximide—Vomiting—Topiramate—epilepsy syndrome	1.05e-05	0.000327	CcSEcCtD
Methsuximide—Rash—Topiramate—epilepsy syndrome	1.04e-05	0.000325	CcSEcCtD
Methsuximide—Dermatitis—Topiramate—epilepsy syndrome	1.04e-05	0.000324	CcSEcCtD
Methsuximide—Headache—Topiramate—epilepsy syndrome	1.03e-05	0.000323	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—HES1—epilepsy syndrome	1.03e-05	0.000595	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—FYN—epilepsy syndrome	1e-05	0.000578	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—HES1—epilepsy syndrome	9.96e-06	0.000576	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MEF2C—epilepsy syndrome	9.95e-06	0.000575	CbGpPWpGaD
Methsuximide—Nausea—Topiramate—epilepsy syndrome	9.77e-06	0.000306	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—FYN—epilepsy syndrome	9.69e-06	0.00056	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MEF2C—epilepsy syndrome	9.63e-06	0.000557	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—MMP9—epilepsy syndrome	9.61e-06	0.000556	CbGpPWpGaD
Methsuximide—Glutethimide—CYP2D6—epilepsy syndrome	9.56e-06	0.0071	CrCbGaD
Methsuximide—Ethotoin—CYP2C19—epilepsy syndrome	9.02e-06	0.00669	CrCbGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	8.93e-06	0.000516	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	8.93e-06	0.000516	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—SRC—epilepsy syndrome	8.86e-06	0.000512	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—FGF2—epilepsy syndrome	8.67e-06	0.000501	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—VEGFA—epilepsy syndrome	8.63e-06	0.000499	CbGpPWpGaD
Methsuximide—Primidone—CYP2C19—epilepsy syndrome	8.36e-06	0.0062	CrCbGaD
Methsuximide—CACNA1G—Developmental Biology—KDR—epilepsy syndrome	8.24e-06	0.000476	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—RELA—epilepsy syndrome	8.05e-06	0.000465	CbGpPWpGaD
Methsuximide—Antipyrine—CYP2D6—epilepsy syndrome	8.01e-06	0.00595	CrCbGaD
Methsuximide—CACNA1H—Developmental Biology—KDR—epilepsy syndrome	7.98e-06	0.000461	CbGpPWpGaD
Methsuximide—Phenytoin—ABCC2—epilepsy syndrome	7.92e-06	0.00588	CrCbGaD
Methsuximide—CACNA1G—Developmental Biology—IL6ST—epilepsy syndrome	7.9e-06	0.000457	CbGpPWpGaD
Methsuximide—Pethidine—SLC6A4—epilepsy syndrome	7.89e-06	0.00585	CrCbGaD
Methsuximide—Methylphenobarbital—CYP2C19—epilepsy syndrome	7.85e-06	0.00582	CrCbGaD
Methsuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	7.83e-06	0.000453	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—IL6ST—epilepsy syndrome	7.65e-06	0.000442	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP11A1—epilepsy syndrome	7.63e-06	0.000441	CbGpPWpGaD
Methsuximide—Phenobarbital—ABCC2—epilepsy syndrome	7.6e-06	0.00564	CrCbGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP11A1—epilepsy syndrome	7.52e-06	0.000435	CbGpPWpGaD
Methsuximide—Pethidine—CYP2C19—epilepsy syndrome	7.48e-06	0.00555	CrCbGaD
Methsuximide—CYP2C19—Arachidonic acid metabolism—PTGS2—epilepsy syndrome	7.23e-06	0.000418	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—MMP9—epilepsy syndrome	7.09e-06	0.00041	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP2D6—epilepsy syndrome	6.88e-06	0.000398	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—MMP9—epilepsy syndrome	6.86e-06	0.000397	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MMP9—epilepsy syndrome	6.86e-06	0.000397	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—CYP2D6—epilepsy syndrome	6.79e-06	0.000392	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	6.77e-06	0.000391	CbGpPWpGaD
Methsuximide—Antipyrine—PTGS2—epilepsy syndrome	6.73e-06	0.00499	CrCbGaD
Methsuximide—CACNA1G—Axon guidance—SRC—epilepsy syndrome	6.53e-06	0.000378	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—FGF2—epilepsy syndrome	6.39e-06	0.000369	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—VEGFA—epilepsy syndrome	6.36e-06	0.000368	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	6.35e-06	0.000367	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—SRC—epilepsy syndrome	6.33e-06	0.000366	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—SRC—epilepsy syndrome	6.32e-06	0.000366	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	6.19e-06	0.000358	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—FGF2—epilepsy syndrome	6.19e-06	0.000358	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—VEGFA—epilepsy syndrome	6.16e-06	0.000356	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—VEGFA—epilepsy syndrome	6.16e-06	0.000356	CbGpPWpGaD
Methsuximide—Clobazam—CYP2C19—epilepsy syndrome	6.04e-06	0.00448	CrCbGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	5.96e-06	0.000345	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—RELA—epilepsy syndrome	5.93e-06	0.000343	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—RELA—epilepsy syndrome	5.75e-06	0.000332	CbGpPWpGaD
Methsuximide—Pethidine—CYP2D6—epilepsy syndrome	5.54e-06	0.00411	CrCbGaD
Methsuximide—Phenytoin—CYP2C19—epilepsy syndrome	5.51e-06	0.00409	CrCbGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	5.41e-06	0.000313	CbGpPWpGaD
Methsuximide—Phenobarbital—CYP2C19—epilepsy syndrome	5.28e-06	0.00392	CrCbGaD
Methsuximide—CACNA1I—Developmental Biology—TNF—epilepsy syndrome	5.28e-06	0.000305	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CA13—epilepsy syndrome	5.25e-06	0.000303	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MMP9—epilepsy syndrome	5.06e-06	0.000292	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MMP9—epilepsy syndrome	4.9e-06	0.000283	CbGpPWpGaD
Methsuximide—Ketazolam—ALB—epilepsy syndrome	4.74e-06	0.00352	CrCbGaD
Methsuximide—CACNA1G—Developmental Biology—SRC—epilepsy syndrome	4.66e-06	0.00027	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—VEGFA—epilepsy syndrome	4.54e-06	0.000263	CbGpPWpGaD
Methsuximide—Ketazolam—ABCB1—epilepsy syndrome	4.52e-06	0.00336	CrCbGaD
Methsuximide—CACNA1H—Developmental Biology—SRC—epilepsy syndrome	4.52e-06	0.000261	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—VEGFA—epilepsy syndrome	4.4e-06	0.000254	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	4.23e-06	0.000244	CbGpPWpGaD
Methsuximide—Pethidine—ALB—epilepsy syndrome	4.15e-06	0.00308	CrCbGaD
Methsuximide—CYP2C19—Metabolism—GLUD1—epilepsy syndrome	3.98e-06	0.00023	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CERS1—epilepsy syndrome	3.98e-06	0.00023	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—L2HGDH—epilepsy syndrome	3.98e-06	0.00023	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PDXK—epilepsy syndrome	3.98e-06	0.00023	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—FAR1—epilepsy syndrome	3.98e-06	0.00023	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ADK—epilepsy syndrome	3.98e-06	0.00023	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—AKT1—epilepsy syndrome	3.93e-06	0.000227	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—TNF—epilepsy syndrome	3.89e-06	0.000225	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—TNF—epilepsy syndrome	3.77e-06	0.000218	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GAMT—epilepsy syndrome	3.64e-06	0.00021	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—EPM2A—epilepsy syndrome	3.64e-06	0.00021	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NHLRC1—epilepsy syndrome	3.64e-06	0.00021	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PNPO—epilepsy syndrome	3.64e-06	0.00021	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CA4—epilepsy syndrome	3.38e-06	0.000196	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—QDPR—epilepsy syndrome	3.38e-06	0.000196	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—POMC—epilepsy syndrome	3.37e-06	0.000195	CbGpPWpGaD
Methsuximide—Clobazam—ABCB1—epilepsy syndrome	3.2e-06	0.00237	CrCbGaD
Methsuximide—CYP2C19—Metabolism—COX3—epilepsy syndrome	3.18e-06	0.000184	CbGpPWpGaD
Methsuximide—Phenytoin—ALB—epilepsy syndrome	3.05e-06	0.00227	CrCbGaD
Methsuximide—CYP2C19—Metabolism—PFKL—epilepsy syndrome	3.02e-06	0.000174	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	3.02e-06	0.000174	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	3.02e-06	0.000174	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	3.02e-06	0.000174	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	3.02e-06	0.000174	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	2.93e-06	0.000169	CbGpPWpGaD
Methsuximide—Phenytoin—ABCB1—epilepsy syndrome	2.92e-06	0.00216	CrCbGaD
Methsuximide—CACNA1G—Developmental Biology—AKT1—epilepsy syndrome	2.9e-06	0.000167	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—AKT1—epilepsy syndrome	2.81e-06	0.000162	CbGpPWpGaD
Methsuximide—Phenobarbital—ABCB1—epilepsy syndrome	2.79e-06	0.00207	CrCbGaD
Methsuximide—CYP2C19—Metabolism—UPB1—epilepsy syndrome	2.76e-06	0.000159	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ATIC—epilepsy syndrome	2.76e-06	0.000159	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NEU1—epilepsy syndrome	2.76e-06	0.000159	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	2.65e-06	0.000153	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GBE1—epilepsy syndrome	2.56e-06	0.000148	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	2.56e-06	0.000148	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	2.51e-06	0.000145	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	2.41e-06	0.000139	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	2.35e-06	0.000136	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NT5E—epilepsy syndrome	2.29e-06	0.000132	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALAD—epilepsy syndrome	2.29e-06	0.000132	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	2.18e-06	0.000126	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	2.18e-06	0.000126	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	2.13e-06	0.000123	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ADSL—epilepsy syndrome	2.09e-06	0.000121	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GLUL—epilepsy syndrome	2.05e-06	0.000118	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	2.01e-06	0.000116	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	1.88e-06	0.000109	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—AQP1—epilepsy syndrome	1.83e-06	0.000106	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.75e-06	0.000101	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	1.65e-06	9.55e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	1.65e-06	9.55e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.54e-06	8.89e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.51e-06	8.71e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.35e-06	7.79e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.3e-06	7.54e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.3e-06	7.49e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.18e-06	6.83e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.18e-06	6.81e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.12e-06	6.48e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.12e-06	6.45e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.06e-06	6.15e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.05e-06	6.09e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—TH—epilepsy syndrome	1.05e-06	6.07e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.03e-06	5.97e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	8.76e-07	5.06e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CAT—epilepsy syndrome	8.64e-07	4.99e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	8.41e-07	4.86e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GPX1—epilepsy syndrome	7.81e-07	4.52e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—AGT—epilepsy syndrome	6.85e-07	3.96e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—APOE—epilepsy syndrome	6.71e-07	3.88e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—POMC—epilepsy syndrome	5.77e-07	3.33e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALB—epilepsy syndrome	5.26e-07	3.04e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	4.6e-07	2.66e-05	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—AKT1—epilepsy syndrome	2.31e-07	1.34e-05	CbGpPWpGaD
